Asthma drug mepolizumab tested in polish patients – results show promise
NCT ID NCT05091385
First seen Feb 01, 2026 · Last updated May 16, 2026 · Updated 17 times
Summary
This study followed 106 adults with severe eosinophilic asthma in Poland who received mepolizumab injections every 4 weeks for at least a year. Researchers tracked how many asthma attacks patients had and whether they needed oral steroids. The goal was to see if the drug helps control the disease in everyday medical practice.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ASTHMA; EOSINOPHILIC are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Medical University of Lodz, Dept. of Immunology and Allergy
Lodz, 92-213, Poland
Conditions
Explore the condition pages connected to this study.